Funding rounds · Week 37 · 13 September 2026
weekly · 7d window · SEC Form D
All funding rounds editions →$66.0m
$66.0m of $66.5m target
Iambic Therapeutics, Inc.
Iambic Therapeutics develops small molecule medicines using an artificial intelligence drug discovery platform. The system integrates molecular design, prediction and experimental data to select candidates for clinical development.
- Appearances
- 1
- Categories
- 1
- First seen
- 13 September 2026
- Latest
- 13 September 2026
01/
Appearance history
1 appearanceThis page records every appearance of the same entity in the reviewed RiseFinder exports. Rankings keep the original category, period and measurement direction.
02/
Get email updates
Join the listGet early signals on the websites, apps, repositories and startups gaining momentum. Join the list for Risefinder email briefings.
Be first to receive the briefing.